NIH-funded research R01 grant

Exploring the use and effects of ketamine in medical and recreational contexts

Official title: Investigating the Ketamine Landscape: Availability, Medical and Recreational Use, and Effects

Funded at New York University School of Medicine · NIH-11061801 · Data updated 2026-11-12

This study looks at how ketamine is being used for treating depression and as a recreational drug, focusing on its safety and effectiveness, so that patients can better understand its risks and benefits.

More Ketamine research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$678,313
NIH project number5R01DA060207-02
Project IDNIH-11061801 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals aged 21 and older who are either prescribed ketamine for medical purposes or are involved in recreational use.

Less likely to help

Patients who are under 21 years old or those who do not use ketamine in any form may not receive benefits from this research.

What this research studies

This research investigates the increasing use of ketamine, both as a prescribed medication for conditions like depression and as a recreational drug. It aims to gather data on prescribing practices, medical and nonmedical use, and the associated risks such as poisonings and adverse events. By analyzing trends in the New York City tristate area, the study seeks to understand how media and cultural perceptions influence ketamine's use. Patients may benefit from insights into the safety and efficacy of ketamine treatments.

Why it matters

Potential benefit: If successful, this research could provide valuable information on the safe use of ketamine and help mitigate risks associated with its misuse.

How similar studies have gone: Previous research has shown promising results in understanding the effects of ketamine, but this study aims to provide a comprehensive view of both medical and recreational use, making it a novel approach.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Palamar, Joseph J — New York University School of Medicine
  • Study coordinator: Palamar, Joseph J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.